Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haolong Lin

Showing results (11-20 of 12) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 12 results.
Journal for Immunotherapy of Cancer|November 30, 2025
CD5 ablation enhances persistence and antitumor potency of engineered T cells by mitigating exhaustion and promoting cytotoxicityJia Wu, Jiali Cheng, Li Zhu, et al.
Science Translational Medicine|May 7, 2025
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacyJiahao Liu, Xiaofei Jiao, Wei Mu, et al.
Pageof 2

Showing results (11-20 of 12) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 12 results.
Journal for Immunotherapy of Cancer|November 30, 2025
CD5 ablation enhances persistence and antitumor potency of engineered T cells by mitigating exhaustion and promoting cytotoxicityJia Wu, Jiali Cheng, Li Zhu, et al.
Science Translational Medicine|May 7, 2025
Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacyJiahao Liu, Xiaofei Jiao, Wei Mu, et al.
Pageof 2